2025-05-28
Enterovirus 71 (EV-71) Nucleic Acid Detection Kit
DTK326, Enterovirus 71 (EV-71) Nucleic Acid Detection Kit(Fluorescent PCR Method) Enterovirus Type 71 (EV-71) belongs to the small RNA virus species and is one of the main pathogens causing hand, foot, and mouth disease (HFMD) in infants and young children. EV-71 infection clinically manifests as herpes on the hands, feet, mouth, and
2025-05-19
Porcine Circovirus Type 2/Type 3 (PCV-2/PCV-3) Nucleic Acid Detection Kit (Dual Fluorescent PCR Method)
DTK425, Porcine Circovirus Type 2 Type 3 (PCV-2 PCV-3) Nucleic Acid Detection Kit (Dual Fluorescent PCR Method). This kit is designed with specific primers and probes based on the conserved regions of porcine circovirus type 2 and type 3 genes. Fluorescence PCR technology is used for in vitro amplification and detection of PCV-2 and PCV-3 nucleic acids, which are used for
2025-05-19
Porcine Circovirus Type 1 (PCV-1) Nucleic Acid Detection Kit (Fluorescent PCR Method)
DTK096, Porcine Circovirus Type 1 (PCV-1) Nucleic Acid Detection Kit (Fluorescent PCR Method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of porcine circovirus type 1 specific primers, and combines them with a specific probe to amplify and detect the DNA of porcine circovirus type 1 in vitro using fluorescence
2025-05-19
Porcine Circovirus Type 3 (PCV-3) Nucleic Acid Detection Kit (Fluorescent PCR Method)
DTK093, Porcine Circovirus Type 3 (PCV-3) Nucleic Acid Detection Kit (Fluorescent PCR Method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of porcine circovirus type 3 specific primers, and combines them with a specific probe to amplify and detect the nucleic acid of porcine circovirus type 3 in vitro using
2025-05-19
Porcine Circovirus Type 2 (PCV-2) Nucleic Acid Detection Kit (Fluorescent PCR Method)
DTK088, Porcine Circovirus Type 2 (PCV-2) Nucleic Acid Detection Kit (Fluorescent PCR Method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of porcine circovirus type 2 specific primers, and combines them with a specific probe to amplify and detect the DNA of porcine circovirus type 2 in vitro using fluorescence
2025-04-16
Ovine Babesiosis (Babesiosis) Nucleic Acid Detection Kit (Fluorescent PCR Method)
DTK569, Ovine Babesiosis (Babesiosis) Nucleic Acid Detection Kit (Fluorescent PCR Method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of specific primers, combines with a specific probe, and uses fluorescence PCR technology to amplify and detect the DNA of Babesia lamblia and Babesia bicalcarata in vitro, for clinical pathogen diagnosis of suspected infected individuals.
2025-04-16
Human Herpesvirus 6/7/8 Nucleic Acid Detection Kit (Triple Fluorescent PCR Method)
DTK537, Human Herpesvirus 6 7 8 Nucleic Acid Detection Kit (Triple Fluorescent PCR Method). This kit is designed based on the principle of fluorescence PCR technology, with specific primers and Taqman probes designed for human herpesvirus 6/7/8.
2025-04-16
Cryptosporidium bovis (CT) nucleic acid detection kit (fluorescent PCR method)
DTK514, Cryptosporidium bovis (CT) nucleic acid detection kit (fluorescent PCR method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of specific primers for bovine cryptosporidium, combines with a specific probe, and uses fluorescence PCR technology to amplify and detect the DNA of bovine cryptosporidium in vitro, thus achieving the goal of rapid detection.
2025-04-16
Porcine Parvovirus (PPV) Nucleic Acid Detection Kit (Fluorescent PCR Method)
DTK079, Porcine Parvovirus (PPV) Nucleic Acid Detection Kit (Fluorescent PCR Method). This kit uses TaqMan probe method for real-time fluorescence PCR technology, designs a pair of porcine parvovirus specific primers, and combines them with a specific probe to amplify and detect the DNA of porcine parvovirus in vitro using fluorescence PCR technology, which is used for pathogen diagnosis of suspected infected individuals in clinical practice.